Cellectis (CLLS) Cash & Equivalents Growth (1y) (2015 - 2026)
Cellectis (CLLS) Cash & Equivalents Growth (1y) (2015 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Cash & Equiv. Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
988.88% |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
-68.22% |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
0.00% |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
3.35% |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
4.77% |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
269.98% |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
17.50% |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Cellectis |
17.40 Bn |
17.21 Bn |
- |
-75.68% |
| Date | Value |
|---|
| Mar 31, 2026 |
-75.68% |
| Dec 31, 2025 |
-57.05% |
| Sep 30, 2025 |
-61.78% |
| Jun 30, 2025 |
-59.87% |
| Mar 31, 2025 |
4.79% |
| Dec 31, 2024 |
4.79% |
| Sep 30, 2024 |
46.66% |
| Jun 30, 2024 |
59.89% |
| Mar 31, 2024 |
46.66% |
| Dec 31, 2023 |
46.66% |
| Sep 30, 2023 |
-49.79% |
| Jun 30, 2023 |
-49.79% |
| Mar 31, 2023 |
-39.81% |
| Dec 31, 2022 |
-49.79% |
| Sep 30, 2022 |
-11.90% |
| Jun 30, 2022 |
-25.21% |
| Mar 31, 2022 |
-25.35% |
| Dec 31, 2021 |
-23.02% |
| Sep 30, 2021 |
-38.12% |
| Jun 30, 2021 |
-4.79% |
